M
Last Price
52 Week Range
CA$0.01 - CA$0.26
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | CA$1.90M |
EV | - |
Shares Outstanding | 63.41M |
Beta | -14.39 |
Industry | - |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
M
Moss Genomics Inc.
MOSS
Sector
Industry
CEO
Liu, Chengqi
Employees
Website
www.mossgenomics.comIPO Date
Headquarters
1030 West Georgia Street, Suite 907, Vancouver, British Columbia, V6E 2Y3, Canada
The current price of Moss Genomics (MOSS) is CA$0.03. Last updated: March 7, 2026 at 7:53 PM Eastern Time
Over the last year, Moss Genomics (MOSS) has established a 52-week price range between a high of CA$0.26 and a low of CA$0.01. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 7:53 PM Eastern Time
Moss Genomics (MOSS) is considered a low volatility stock. It has a beta of -14.39, which means it typically moves in the opposite direction of the broader market, with a magnitude of approximately 14.39 times the market's movement. Over the past 52 weeks, MOSS has traded within a CA$0.01 – CA$0.26 range. Last updated: March 7, 2026 at 7:53 PM Eastern Time
The current Moss Genomics (MOSS) market capitalization is approximately CA$1.90M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Moss Genomics's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 7:53 PM Eastern Time
Moss Genomics (MOSS) does not currently pay a dividend. Over the last twelve months (LTM), the company paid CA$0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, Moss Genomics (MOSS) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: March 7, 2026 at 7:53 PM Eastern Time
Like other publicly traded stocks, Moss Genomics (MOSS) shares are bought and sold on stock exchanges such as CNSX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Moss Genomics (MOSS) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add MOSS to your watchlist.
Moss Genomics trades under the ticker symbol MOSS on the CNSX stock exchange. The ticker MOSS is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers